Ozogamisin

Ozogamisin
Pengenal
  • metil(1R,4Z,8S,13E )-13-[2-[[2-[[[p-(3-karbamoilpropoksi)-α-metilbenzilidena]hidrazino]karbonil]-1,1-dimetiletil]ditio]etilidena]-8-[[4,6-dideoksi-4-[[[2,6-dideoksi-4-S-[4-[(6-deoksi-3-O-metil-α-L-mannopiranosil)oksi]-3-iodo-5,6-dimetoksi-o-toluoil]-4-tio-β-D-ribo-heksopiranosil]oksi]amino]-2-O-[2,4-dideoksi-4-(N-etilasetamido)-3-O-metil-α-L-treo-pentopiranosil]-β-D-glukopiranosil]oksi]-1-hidroksi-11-oksobisiklo[7.3.1]trideka-4,9-diena-2,6-diina-10-karbamat[1]: 5 
Nomor CAS
UNII
CompTox Dashboard (EPA)
Data sifat kimia dan fisik
RumusC73H97IN6O25S3
Massa molar1.681,68 g·mol−1
Model 3D (JSmol)
  • CCN(C1COC(CC1OC)OC2C(C(C(OC2OC3C#CC=CC#CC4(CC(=O)C(=C3C4=CCSSC(C)(C)CC(=O)NN=C(C)C5=CC=C(C=C5)OCCCC(=O)N)NC(=O)OC)O)C)NOC6CC(C(C(O6)C)SC(=O)C7=C(C(=C(C(=C7OC)OC)OC8C(C(C(C(O8)C)O)OC)O)I)C)O)O)C(=O)C
  • InChI=1S/C73H97IN6O25S3/c1-15-80(41(7)81)45-35-98-52(32-49(45)92-10)103-65-60(87)57(79-105-53-31-46(82)67(40(6)99-53)107-68(89)54-36(2)56(74)63(66(95-13)62(54)93-11)104-69-61(88)64(94-12)59(86)39(5)101-69)38(4)100-70(65)102-48-21-18-16-17-19-28-73(91)33-47(83)58(76-71(90)96-14)55(48)44(73)27-30-106-108-72(8,9)34-51(85)78-77-37(3)42-23-25-43(26-24-42)97-29-20-22-50(75)84/h16-17,23-27,38-40,45-46,48-49,52-53,57,59-61,64-65,67,69-70,79,82,86-88,91H,15,20,22,29-35H2,1-14H3,(H2,75,84)(H,76,90)(H,78,85)/b17-16-,44-27+,77-37+/t38-,39+,40-,45+,46+,48+,49+,52+,53+,57-,59+,60+,61-,64-,65-,67-,69+,70+,73+/m1/s1
  • Key:HNMATTJJEPZZMM-BPKVFSPJSA-N

Istilah ozogamisin dalam nama antibodi monoklonal atau konjugat obat-antibodi menunjukkan bahwa antibodi tersebut dihubungkan dengan agen sitotoksik dari kelas kalicheamicin.[2]

Lihat juga

Referensi

  1. ^ "マイロターグ点滴静注用5mg インタビューフォーム" [Mylotarg 5mg for intravenous drip infusion interview form] (PDF). www.info.pmda.go.jp (dalam bahasa Japanese). Diakses tanggal 2021-12-28.{{cite web}}: Pemeliharaan CS1: Bahasa yang tidak diketahui (link)
  2. ^ Jabbour E, Paul S, Kantarjian H (July 2021). "The clinical development of antibody-drug conjugates - lessons from leukaemia". Nature Reviews. Clinical Oncology. 18 (7): 418–433. doi:10.1038/s41571-021-00484-2. PMID 33758376. S2CID 232329035.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.
Kembali kehalaman sebelumnya